Tarsus Pharmaceuticals had a revenue of 102.66M in the quarter ending Jun 30, 2025, with 31.05%. This bring the company's revenue in the last twelve months to 295.52M, Decreased 26.47%. In the fiscal year ending Dec 31, 2024, Tarsus Pharmaceuticals had annual revenue of 182.95M with 948.62% growth.